Attached files
| file | filename |
|---|---|
| EX-4.1 - EXHIBIT 4.1 - ABVC BIOPHARMA, INC. | s102891_4-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 21, 2016
| American BriVision (Holding) Corporation |
| (Exact name of registrant as specified in its charter) |
| Nevada | 333-91436 | 26-0014658 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
11 Sawyers Peak Drive, Goshen, NY, 10924
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (845) 551-8728
| METU BRANDS, INC. |
| (Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On March 21, 2016, the Board of Directors of American BriVision (Holding) Corporation (the “Company” or “we”, “us”) approved an amendment to Articles of Incorporation to effect a forward split at a ratio of 1 to 3:141 and increase the number of our authorized shares of common stock, par value $0.001 per share, to 360,000,000, which we expect to be effective on or after April 6, 2016. The amendment to Articles of Incorporation was approved by the majority of the shareholders of the Company.
Item 9.01 Financial Statements and Exhibits
| Exhibit No. | Description |
| 4.1 | Amendment to Article of Incorporation. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| American BriVision (Holding) Corporation | ||
| Date: March 28, 2016 | By: | /s/ Eugene Jiang |
| Eugene Jiang | ||
| Chief Executive Officer and Chairman | ||